Literature DB >> 6408261

Inhibition of bacterial binding to mouse macrophages by Pseudomonas alginate.

A M Oliver, D M Weir.   

Abstract

Alginate, an acetylated polymer of D-mannuronic and L-guluronic acid obtained from a mucoid strain of Pseudomonas aeruginosa was shown to inhibit the binding of an isogenic non-mucoid revertant to mouse peritoneal and pulmonary macrophages. Inhibition of bacterial binding by the alginate was also demonstrated in tests with other non-mucoid P. aeruginosa strains and a strain of Staphylococcus albus. Since the mucoid form of P. aeruginosa eventually predominates in chronic P. aeruginosa infection in patients with cystic fibrosis, it is postulated that the alginate's inhibition of binding gives mucoid forms a selective advantage over non-mucoid forms against macrophage defence mechanisms in the lung.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408261

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  11 in total

1.  Global genomic analysis of AlgU (sigma(E))-dependent promoters (sigmulon) in Pseudomonas aeruginosa and implications for inflammatory processes in cystic fibrosis.

Authors:  Aaron M Firoved; J Cliff Boucher; Vojo Deretic
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

2.  Hypochlorite scavenging by Pseudomonas aeruginosa alginate.

Authors:  D B Learn; E P Brestel; S Seetharama
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

3.  Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa.

Authors:  Aaron M Firoved; Vojo Deretic
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

4.  Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics.

Authors:  G T Mai; J G McCormack; W K Seow; G B Pier; L A Jackson; Y H Thong
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

Review 5.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

Authors:  T B May; D Shinabarger; R Maharaj; J Kato; L Chu; J D DeVault; S Roychoudhury; N A Zielinski; A Berry; R K Rothmel
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

Review 6.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

7.  Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro.

Authors:  D P Krieg; R J Helmke; V F German; J A Mangos
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

8.  Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments.

Authors:  G T Mai; W K Seow; G B Pier; J G McCormack; Y H Thong
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Nonopsonic phagocytosis of nonmucoid Pseudomonas aeruginosa by human neutrophils and monocyte-derived macrophages is correlated with bacterial piliation and hydrophobicity.

Authors:  D P Speert; B A Loh; D A Cabral; I E Salit
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

10.  The effect of Pseudomonas alginate on rat alveolar macrophage phagocytosis and bacterial opsonization.

Authors:  A M Oliver; D M Weir
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.